Related Experiment Video
Updated: Jul 5, 2026

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
Hydrocortisone modulates cholera toxin endocytosis by regulating immature enterocyte plasma membrane phospholipids
Lei Lu1, Yuanwu Bao, Abdullah Khan
1Developmental Gastroenterology Laboratory, Massachusetts General Hospital for Children, Boston, Massachusetts, USA. lul@helix.mgh.harvard.edu
Insights
Neonates are susceptible to diarrhea due to immature enterocytes. This study reveals that developmental changes in cholera toxin (CT) endocytosis are linked to increased GM1-lipid raft association in developing intestinal cells.
Area of Science:
- Gastroenterology
- Cell Biology
- Pediatric Infectious Diseases
Background:
- Diarrheal diseases pose a significant global health burden, particularly in infants and children.
- Immature enterocytes in neonates may contribute to increased susceptibility to diarrhea caused by bacterial toxins.
Purpose of the Study:
- To investigate developmental differences in cholera toxin (CT)-GM1-mediated endocytosis in human intestinal cells.
Main Methods:
- Utilized fetal and mature human intestinal epithelial cell lines (H4, T84), primary cells, and xenografts.
- Employed hydrocortisone to induce enterocyte maturation.
- Analyzed CT-GM1 endocytosis pathways using electron microscopy and lipid raft association studies.
Main Results:
- Observed increased CT-caveolae and decreased CT-clathrin colocalization in mature versus immature enterocytes.
- Found significant GM1 partitioning into lipid rafts in mature cells, which was enhanced by hydrocortisone.
- Demonstrated that maturational changes in phospholipid composition, including increased phosphatidylcholine and sphingomyelin, correlate with enhanced CT-GM1/lipid raft association.
Conclusions:
- Developmental changes in CT endocytosis are partly attributed to increased GM1-lipid raft association.
- Maturation of enterocyte phospholipid composition plays a crucial role in regulating CT endocytosis.
Background & Aims:
Diarrheal disease is a major cause of morbidity and mortality in infants and children worldwide. Evidence has indicated immature human enterocytes and their interaction with bacteria and enterotoxins may account for the noted increased susceptibility of neonates to diarrhea. Our aim was to characterize the developmental difference in cholera toxin (CT)-GM1-mediated endocytosis.
Methods:
We used H4 cells (a fetal human small intestinal epithelial cell line), T84 cells, primary cultured mature human small intestinal epithelial cells, and human fetal small intestine xenografts. In addition, hydrocortisone was used as a potent intestinal trophic factor to induce maturation of the human enterocytes.
Results:
Here we show an increase in CT-caveolae and a decrease in CT-clathrin colocalization in H4/hydrocortisone compared with H4 cells by electron microscopy. In T84 and freshly isolated human small intestinal epithelial cells, a significant amount of GM1 was partitioned into the lipid rafts. In contrast, there was little CT-GM1/lipid raft association in H4 cells. However, hydrocortisone significantly increased GM1/lipid raft association in H4 cells. Furthermore, we noted an increase in the level of phosphatidylcholine, sphingomyelin, and the ratio of phosphatidylcholine/phosphatidylinositol in mature compared with immature enterocytes and that hydrocortisone can accelerate this maturational process. Disruption of phosphatidylinositol transfer protein alpha using small interference RNA showed an increase in GM1/lipid raft association in H4 cells and resulted in a decreased CT response.
Conclusions:
Our studies suggest that the developmental change in CT endocytosis is partially caused by an increased GM1-lipid raft association through a maturational change of phospholipid composition on the cell surface of immature enterocytes.
Related Concept Videos
Cholera
GPCRs Regulate Adenylyl Cylase Activity
Two...
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease III: Crohn's Disease

